Panaxia Labs Israel Stock Number Of Employees
| HROD Stock | 5,700 448.00 8.53% |
Panaxia Labs Israel fundamentals help investors to digest information that contributes to Panaxia Labs' financial success or failures. It also enables traders to predict the movement of Panaxia Stock. The fundamental analysis module provides a way to measure Panaxia Labs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Panaxia Labs stock.
Panaxia |
Panaxia Labs Israel Company Number Of Employees Analysis
Panaxia Labs' Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
| Competition |
Based on the recorded statements, Panaxia Labs Israel is currently employing 0.0 people. This indicator is about the same for the Other average (which is currently at 0.0) sector and about the same as Other (which currently averages 0.0) industry. This indicator is about the same for all Israel stocks average (which is currently at 0.0).
Panaxia Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Panaxia Labs' direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Panaxia Labs could also be used in its relative valuation, which is a method of valuing Panaxia Labs by comparing valuation metrics of similar companies.Panaxia Labs is currently under evaluation in number of employees category among its peers.
Panaxia Fundamentals
| EBITDA | (15.07 M) | |||
| Net Income | 2.73 M | |||
| Cash And Equivalents | 2.6 M | |||
| Cash Per Share | 0.83 X | |||
| Total Debt | 13.21 M | |||
| Current Ratio | 2.79 X | |||
| Book Value Per Share | (6.55) X | |||
| Cash Flow From Operations | (1.7 M) | |||
| Earnings Per Share | (0.26) X | |||
| Beta | 1.17 | |||
| Market Capitalization | 57.97 M | |||
| Total Asset | 18.08 M | |||
| Z Score | 2.4 | |||
| Net Asset | 18.08 M |
About Panaxia Labs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Panaxia Labs Israel's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Panaxia Labs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Panaxia Labs Israel based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Panaxia Stock
Panaxia Labs financial ratios help investors to determine whether Panaxia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Panaxia with respect to the benefits of owning Panaxia Labs security.